574 related articles for article (PubMed ID: 34414447)
21. Gut Microbial Metabolites in Parkinson's Disease: Implications of Mitochondrial Dysfunction in the Pathogenesis and Treatment.
Liang Y; Cui L; Gao J; Zhu M; Zhang Y; Zhang HL
Mol Neurobiol; 2021 Aug; 58(8):3745-3758. PubMed ID: 33825149
[TBL] [Abstract][Full Text] [Related]
22. Unexpected Implication of SRP and AGO2 in Parkinson's Disease: Involvement in Alpha-Synuclein Biogenesis.
Hernandez SM; Tikhonova EB; Baca KR; Zhao F; Zhu X; Karamyshev AL
Cells; 2021 Oct; 10(10):. PubMed ID: 34685771
[TBL] [Abstract][Full Text] [Related]
23. A30P α-synuclein impairs dopaminergic fiber regeneration and interacts with L-DOPA replacement in MPTP-treated mice.
Szego ÉM; Gerhardt E; Kermer P; Schulz JB
Neurobiol Dis; 2012 Jan; 45(1):591-600. PubMed ID: 22001606
[TBL] [Abstract][Full Text] [Related]
24. Human myeloperoxidase (hMPO) is expressed in neurons in the substantia nigra in Parkinson's disease and in the hMPO-α-synuclein-A53T mouse model, correlating with increased nitration and aggregation of α-synuclein and exacerbation of motor impairment.
Maki RA; Holzer M; Motamedchaboki K; Malle E; Masliah E; Marsche G; Reynolds WF
Free Radic Biol Med; 2019 Sep; 141():115-140. PubMed ID: 31175983
[TBL] [Abstract][Full Text] [Related]
25. The immunology of Parkinson's disease.
Zhu B; Yin D; Zhao H; Zhang L
Semin Immunopathol; 2022 Sep; 44(5):659-672. PubMed ID: 35674826
[TBL] [Abstract][Full Text] [Related]
26. Digesting recent findings: gut alpha-synuclein, microbiome changes in Parkinson's disease.
Anis E; Xie A; Brundin L; Brundin P
Trends Endocrinol Metab; 2022 Feb; 33(2):147-157. PubMed ID: 34949514
[TBL] [Abstract][Full Text] [Related]
27. Targeting Microglial α-Synuclein/TLRs/NF-kappaB/NLRP3 Inflammasome Axis in Parkinson's Disease.
Li Y; Xia Y; Yin S; Wan F; Hu J; Kou L; Sun Y; Wu J; Zhou Q; Huang J; Xiong N; Wang T
Front Immunol; 2021; 12():719807. PubMed ID: 34691027
[TBL] [Abstract][Full Text] [Related]
28. Upregulation of the p53-p21 pathway by G2019S LRRK2 contributes to the cellular senescence and accumulation of α-synuclein.
Ho DH; Seol W; Son I
Cell Cycle; 2019 Feb; 18(4):467-475. PubMed ID: 30712480
[TBL] [Abstract][Full Text] [Related]
29. Transcellular propagation of fibrillar α-synuclein from enteroendocrine to neuronal cells requires cell-to-cell contact and is Rab35-dependent.
Rodrigues PV; de Godoy JVP; Bosque BP; Amorim Neto DP; Tostes K; Palameta S; Garcia-Rosa S; Tonoli CCC; de Carvalho HF; de Castro Fonseca M
Sci Rep; 2022 Mar; 12(1):4168. PubMed ID: 35264710
[TBL] [Abstract][Full Text] [Related]
30. Chronic stress-induced gut dysfunction exacerbates Parkinson's disease phenotype and pathology in a rotenone-induced mouse model of Parkinson's disease.
Dodiya HB; Forsyth CB; Voigt RM; Engen PA; Patel J; Shaikh M; Green SJ; Naqib A; Roy A; Kordower JH; Pahan K; Shannon KM; Keshavarzian A
Neurobiol Dis; 2020 Feb; 135():104352. PubMed ID: 30579705
[TBL] [Abstract][Full Text] [Related]
31. Role of enteric glia and microbiota-gut-brain axis in parkinson disease pathogenesis.
Claudino Dos Santos JC; Lima MPP; Brito GAC; Viana GSB
Ageing Res Rev; 2023 Feb; 84():101812. PubMed ID: 36455790
[TBL] [Abstract][Full Text] [Related]
32. Antioxidant Nanoparticles for Concerted Inhibition of α-Synuclein Fibrillization, and Attenuation of Microglial Intracellular Aggregation and Activation.
Zhao N; Yang X; Calvelli HR; Cao Y; Francis NL; Chmielowski RA; Joseph LB; Pang ZP; Uhrich KE; Baum J; Moghe PV
Front Bioeng Biotechnol; 2020; 8():112. PubMed ID: 32154238
[TBL] [Abstract][Full Text] [Related]
33. Phosphatidylinositol-3,4,5-trisphosphate interacts with alpha-synuclein and initiates its aggregation and formation of Parkinson's disease-related fibril polymorphism.
Choong CJ; Aguirre C; Kakuda K; Beck G; Nakanishi H; Kimura Y; Shimma S; Nabekura K; Hideshima M; Doi J; Yamaguchi K; Nakajima K; Wadayama T; Hayakawa H; Baba K; Ogawa K; Takeuchi T; Badawy SMM; Murayama S; Nagano S; Goto Y; Miyanoiri Y; Nagai Y; Mochizuki H; Ikenaka K
Acta Neuropathol; 2023 May; 145(5):573-595. PubMed ID: 36939875
[TBL] [Abstract][Full Text] [Related]
34. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
Perfeito R; Cunha-Oliveira T; Rego AC
Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
[TBL] [Abstract][Full Text] [Related]
35. Gut microbiome and Parkinson's disease: Perspective on pathogenesis and treatment.
Salim S; Ahmad F; Banu A; Mohammad F
J Adv Res; 2023 Aug; 50():83-105. PubMed ID: 36332796
[TBL] [Abstract][Full Text] [Related]
36. αSynuclein control of mitochondrial homeostasis in human-derived neurons is disrupted by mutations associated with Parkinson's disease.
Pozo Devoto VM; Dimopoulos N; Alloatti M; Pardi MB; Saez TM; Otero MG; Cromberg LE; Marín-Burgin A; Scassa ME; Stokin GB; Schinder AF; Sevlever G; Falzone TL
Sci Rep; 2017 Jul; 7(1):5042. PubMed ID: 28698628
[TBL] [Abstract][Full Text] [Related]
37. Parkinson's disease and alpha-synucleinopathies: from arising pathways to therapeutic challenge.
Miraglia F; Betti L; Palego L; Giannaccini G
Cent Nerv Syst Agents Med Chem; 2015; 15(2):109-16. PubMed ID: 25896035
[TBL] [Abstract][Full Text] [Related]
38. A Single Chain Fragment Variant Binding Misfolded Alpha-Synuclein Exhibits Neuroprotective and Antigen-Specific Anti-Inflammatory Properties.
Fassler M; Benaim C; George J
Cells; 2022 Nov; 11(23):. PubMed ID: 36497081
[TBL] [Abstract][Full Text] [Related]
39. Rab7 reduces α-synuclein toxicity in rats and primary neurons.
Szegö EM; Van den Haute C; Höfs L; Baekelandt V; Van der Perren A; Falkenburger BH
Exp Neurol; 2022 Jan; 347():113900. PubMed ID: 34695425
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of MPTP-induced α-synuclein oligomerization by fatty acid-binding protein 3 ligand in MPTP-treated mice.
Matsuo K; Cheng A; Yabuki Y; Takahata I; Miyachi H; Fukunaga K
Neuropharmacology; 2019 May; 150():164-174. PubMed ID: 30930168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
